Affiliation:
1. Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan.
2. Research Team for Neuroimaging
Abstract
Abstract
We present 3 patients as pitfalls of amyloid-beta (Aβ) PET, who underwent 11C-PiB (Aβ), 18F-MK-6240 (Alzheimer disease [AD]-tau), and 18F-THK5351 (astrogliosis) PET examinations. Despite negligible or tiny Aβ pathology, patients 1 and 2 were diagnosed with AD as the cause of symptoms. Despite widespread Aβ pathology, patient 3 was not diagnosed with AD as the cause of symptoms. However, if we had only conducted Aβ PET, patients 1 and 2 might not have been diagnosed with AD, whereas patient 3 might have been diagnosed with AD. Hence, both Aβ and AD-tau assessments are necessary to relate clinical symptoms to AD pathology.
Publisher
Ovid Technologies (Wolters Kluwer Health)